Theranostic markers for personalized therapy of spider phobia: Methods of a bicentric external cross‐validation machine learning approach
International Journal of Methods in Psychiatric Research2019Vol. 29(2), pp. e1812–e1812
Citations Over TimeTop 10% of 2019 papers
Hanna Schwarzmeier, Elisabeth J. Leehr, Joscha Böhnlein, Fabian R. Seeger, Kati Roesmann, Bettina Gathmann, Martin J. Herrmann, Niklas Siminski, Markus Junghöfer, Thomas Straube, Dominik Grotegerd, Udo Dannlowski
Abstract
This study will offer cross-validated theranostic markers for predicting the individual success of exposure-based therapy. Findings will support clinical decision-making on personalized therapy, bridge the gap between basic and clinical research, and bring stratified therapy into reach. The study is registered at ClinicalTrials.gov (ID: NCT03208400).
Related Papers
- → Virtual reality exposure therapy of anxiety disorders: A review(2004)486 cited
- → Virtual Reality-Enhanced Extinction of Phobias and Post-Traumatic Stress(2017)188 cited
- → Two-year follow-up after a randomised controlled trial of self- and clinician-accompanied exposure for phobia/panic disorders(2001)37 cited
- → Specific Phobias: Assessment and Treatment(2014)3 cited
- → The feasibility of using computer-based treatment for specific phobia ; A controlled comparison of computer-based vicarious exposure versus live exposure in the treatment of spider phobia(1999)